Compare with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES WYETH LTD ALKEM LABORATORIES/
WYETH LTD
 
P/E (TTM) x - 27.7 - View Chart
P/BV x 6.3 5.3 118.6% View Chart
Dividend Yield % 0.7 1.3 53.6%  

Financials

 ALKEM LABORATORIES   WYETH LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
WYETH LTD
Mar-13
ALKEM LABORATORIES/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1,5891,044 152.1%   
Low Rs1,232818 150.6%   
Sales per share (Unadj.) Rs417.5298.6 139.8%  
Earnings per share (Unadj.) Rs56.357.2 98.3%  
Cash flow per share (Unadj.) Rs64.758.4 110.8%  
Dividends per share (Unadj.) Rs12.7017.00 74.7%  
Dividend yield (eoy) %0.91.8 49.3%  
Book value per share (Unadj.) Rs292.9249.5 117.4%  
Shares outstanding (eoy) m119.5722.72 526.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.1 108.3%   
Avg P/E ratio x25.116.3 154.0%  
P/CF ratio (eoy) x21.815.9 136.7%  
Price / Book Value ratio x4.83.7 129.0%  
Dividend payout %22.629.7 76.0%   
Avg Mkt Cap Rs m168,65321,157 797.2%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m9,171400 2,292.8%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m49,9156,783 735.8%  
Other income Rs m1,645353 466.6%   
Total revenues Rs m51,5617,136 722.5%   
Gross profit Rs m8,4821,617 524.5%  
Depreciation Rs m1,00627 3,781.2%   
Interest Rs m6716 12,192.7%   
Profit before tax Rs m8,4511,938 436.1%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m1,606632 254.0%   
Profit after tax Rs m6,7311,301 517.6%  
Gross profit margin %17.023.8 71.3%  
Effective tax rate %19.032.6 58.2%   
Net profit margin %13.519.2 70.3%  
BALANCE SHEET DATA
Current assets Rs m27,0626,984 387.5%   
Current liabilities Rs m15,3242,056 745.3%   
Net working cap to sales %23.572.6 32.4%  
Current ratio x1.83.4 52.0%  
Inventory Days Days6799 67.0%  
Debtors Days Days4124 172.4%  
Net fixed assets Rs m12,610244 5,161.5%   
Share capital Rs m239227 105.2%   
"Free" reserves Rs m34,4905,441 633.9%   
Net worth Rs m35,0275,668 618.0%   
Long term debt Rs m1,21225 4,846.4%   
Total assets Rs m54,3877,901 688.4%  
Interest coverage x13.6353.3 3.8%   
Debt to equity ratio x00 784.2%  
Sales to assets ratio x0.90.9 106.9%   
Return on assets %13.616.5 82.3%  
Return on equity %19.222.9 83.8%  
Return on capital %24.934.0 73.0%  
Exports to sales %12.90.2 5,932.8%   
Imports to sales %3.136.3 8.5%   
Exports (fob) Rs m6,46115 43,656.1%   
Imports (cif) Rs m1,5402,465 62.5%   
Fx inflow Rs m6,56315 43,179.6%   
Fx outflow Rs m3,0122,677 112.5%   
Net fx Rs m3,552-2,662 -133.4%   
CASH FLOW
From Operations Rs m7,259923 786.2%  
From Investments Rs m1,864317 588.3%  
From Financial Activity Rs m-9,273-481 1,927.8%  
Net Cashflow Rs m-150759 -19.8%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 33.1 11.3 292.9%  
FIIs % 0.0 7.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 30.4 -  
Shareholders   68,381 21,978 311.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DR. REDDYS LAB  PIRAMAL ENTERPRISES  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  PFIZER  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips Over 300 Points; Axis Bank & Tech Mahindra Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Barring consumer durables sector, all sectoral indices are trading in red with stocks in the telecom sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Sep 17, 2019 02:21 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS